HARPER CLINICAL PARTNERS LTDActive

Company number 10992573Private limited companyIncorporated 2017
⚠ Confirmation statement overdue. It was due on 16 Oct 2026.

Key figures

£4,681+22.3%
Net assets 2024/25
+41.5%
Average annual growth 2019/20–2024/25
02 k4 k6 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, HARPER CLINICAL PARTNERS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 k10 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Total assets3,4566,0471,9698,0898,755
Total liabilities1,7894,5222,3864,2624,074
Net assets / total equity1,6671,5254173,8274,681
Average number of employees00022

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: HARPER CLINICAL PARTNERS LTD

Company

HARPER CLINICAL PARTNERS LTD is a private limited company registered with Companies House under company number 10992573. It was incorporated on 3 Oct 2017. Its status is active. The registered office is in Sheffield (S11). Its nature of business (SIC 2007) is general medical practice activities (86210), specialists medical practice activities (86220), physical well-being activities (96040).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files micro-entity accounts. Net assets were £4,681, up 22.3% on the previous year. Total assets were £8,755 and total liabilities £4,074. The company had an average of 2 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

2 persons with significant control are registered.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 16 Oct 2026.